Lucid Group has announced that Eric Muller has joined the agency as Chief Executive Officer. He succeeds CEO and original DiD ...

There is currently no cure for PBC, with treatment aiming to manage symptoms, improve quality of life and slow disease ...

Johnson & Johnson has welcomed Final Draft Guidance from NICE recommending Imbruvica (ibrutinib) with R‑CHOP, alternating with R‑DHAP or R‑DHAOx, followed by ibrutinib monotherapy, for adults with ...

Clinical research is entering a new era: advances in methodological approaches, the growing integration of real-world ...

Clinical trials are becoming increasingly complex. In a 2023 survey, 70% of investigative site staff said conducting studies ...

Pace has appointed Andrew Fenny as President of Pace Life Sciences to lead the division into its next phase of strategic ...

Cell Therapies has manufactured and released the first clinical dose for the KOALA trial, marking the start of a ...

A July 2026 Leerink Partners report named Carterra a core enabling technology in the growing Lab‑in‑the‑Loop market. The ...

Diana F Clarke, Assistant Professor of Paediatrics at Boston University School of Medicine and Lead Investigator of the ...

GSK has announced that the US FDA has accepted for priority review a supplemental Biologics License Application for Jemperli ...

Hi, this project/product/partnership is going live next week – can you do some comms?’ ...

The introduction of oral GLP-1 medicines, alongside growing awareness of injectable treatments such as Wegovy and Mounjaro, ...